The updated labeling provides a new conversion chart for starting dosages when switching patients from subcutaneous mealtime insulin to Afrezza. The Food and Administration (FDA) has approved updated ...
Afrezza (insulin human) is a brand-name inhaled insulin prescribed to manage blood sugar in adults with diabetes. It comes as a powder that you typically take at mealtimes. The dosage can vary based ...
(RTTNews) - MannKind Corporation (MNKD) announced that the U.S. FDA has approved an update to the Afrezza prescribing information, adding new guidance for determining the starting mealtime dose when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results